Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSealand Cap Regulatory News (SCGL)

  • This share is currently suspended. It was suspended at a price of 0.25

Share Price Information for Sealand Cap (SCGL)

Share Price is delayed by 15 minutes
Get Live Data
0.25    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £16.37m
SCGL Live PriceLast checked at - London Stock Exchange

Intraday Sealand Cap Share Chart

Distribution Contracts

7 May 2021 07:00

RNS Number : 8347X
Sealand Capital Galaxy Limited
07 May 2021
 

For release: 07.00 a.m., 7 May 2021

 

Sealand Capital Galaxy Limited

("Sealand" or "the Company")

Distribution Contracts

 

Sealand Capital Galaxy Limited (LSE: SCGL) is delighted to announce that it has entered into exclusive, three-year product-specific distribution contracts with two British brands; Richard James and Czech & Speake, and two Nordic brands; HH Simonsen and INARI Arctic Beauty, for Hong Kong, Macau and mainland China ("the territories").

 

Richard James is a Savile Row tailor and menswear company, and the Company is now the sole distributor of the brand's Aqva Aromatica Scents Collection in the territories. Czech & Speake sells a comprehensive range of men's fragrances, accessories, lavish shaving gift sets and exquisite leather goods, of which Sealand is now also the sole distributor in the territories.

HH Simonsen and INARI Arctic Beauty are respected Nordic brands. HH Simonsen is a Jutland, Denmark-based provider of professional styling tools, brushes and hair products to salons, stylists and consumers. INARI is a Finnish natural skincare brand, with product formulas designed to activate the skin's healing and renewal. Each of their products is a meticulously researched blend of potent, plant-derived actives that are proven with efficacy and are also safe and stable.

The Company is in negotiations for the sale of these products by an internationally known department store in the territories, both online and in store. The Company is also currently in negotiations with other brands regarding similar sole distribution deals, and will update the market accordingly in due course.

 

Nelson Law, Executive Chairman of the Company commented:

 

"We are very proud to be exclusive distributors of these high quality European goods in the Hong Kong, Macau and mainland China markets. We will use our range of digital marketing services and access to influencers to provide a bridge, and the necessary commercial infrastructure, to allow high-end European merchants to enter these highly lucrative markets. There remains strong demand from Chinese consumers in these markets to conveniently purchase desirable, high end European goods. We make this possible.

 

"The perfumers who have created the Aqva Aromatica Scents Collection for Richard James are Michel Almeirac and Alain Verjus. Michel and Alain have, respectively, also created fragrances for Burberry and Pierre Cardin. We look forward to introducing, and reintroducing, consumers in Asia to their work through a new brand. Additionally, we expect the Nordic produced HH Simonsen and INARI products (such as their Rejuvenating Eye Cream, Hydration Cleanser and Lifting Serum) to resonate very strongly with consumers in Asia, as products from this region are highly desirable, and have a reputation for quality and attractive design."

 

-Ends-

 

Enquiries:

 

Sealand Capital Galaxy Limited 

Law Chung Lam Nelson, Executive Chairman

+ 44 (0) 753 795 9788

Novum Securities Limited 

David Coffman

+ 44 (0) 20 7399 9400

 

Notes to Editors:

The Company's Shares are traded on the Official List of the London Stock Exchange's main market for listed securities under the ticker SCGL.

 

Further information on Sealand is available on its website http://www.scg-ltd.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTDZGGKKVGGMZM
Date   Source Headline
30th Apr 20267:00 amRNSAssignment of CLN Investment in EVOO AI plc
29th Apr 20267:48 amRNSTemporary Suspension
30th Mar 202611:50 amRNSDirector/PDMR Shareholding
30th Mar 202611:38 amRNSCLN Conversion, Exercise of Warrants & TVR
26th Mar 202611:48 amRNSResult of General Meeting
16th Mar 20269:19 amRNSDirector/PDMR Shareholding
16th Mar 20269:19 amRNSDirector/PDMR Shareholding
11th Mar 202611:10 amRNSIssue of Equity
6th Mar 20264:54 pmRNSNotice of General Meeting
17th Feb 20267:00 amRNSAppointment of Financial Adviser
27th Jan 20264:00 pmRNSStrategic Update and Business Expansion
21st Jan 20264:00 pmRNSDirector Appointment and CFO Appointment
6th Jan 202612:43 pmRNSStatement re Share Price Movement
8th Dec 20253:00 pmRNSDirector Appointment
7th Nov 202512:05 pmRNSPublication of a Prospectus
30th Sep 20251:30 pmRNSHalf-year Report
22nd May 202510:22 amRNSExercise of Warrants
30th Apr 20255:00 pmRNSResults of General Meetings of Warrant Holders
30th Apr 20254:55 pmRNSFinal Results for the Year Ended 31 December 2024
25th Apr 20254:11 pmRNSNotice of General Meetings of Warrant Holders
14th Mar 20257:00 amRNS-REVOO AI PLC Appoints Gordon Radley as New Director
6th Mar 20257:00 amRNS-REVOO’s acceptance into the NVIDIA Connect Program
28th Feb 20254:33 pmRNS-RCEO Interviewed by StockBox Media
28th Feb 20257:00 amRNSTotal Voting Rights
26th Feb 20257:00 amRNSSelection of Strategic Development Partner
24th Feb 20257:00 amRNS-RCorporate Update - Strategic Growth Initiatives
31st Jan 20254:32 pmRNSExercise of Convertible Loan Note and TVR
27th Jan 20257:00 amRNSFormation of ‘SEA-VOO AI ASIA’
20th Jan 20259:17 amRNSAppointment of Chief Executive Officer
10th Jan 20252:50 pmRNSAGM RESULTS AND INVESTMENT IN EVOO AI PLC
6th Jan 20253:24 pmRNSStatement re Share Price Movement
30th Dec 20247:00 amRNSConditional Issue of Equity and Issue of CLN
16th Dec 20247:00 amRNSNotice of AGM
4th Dec 20242:07 pmRNSShare Price Movement
22nd Nov 202410:08 amRNSConditional Investment Agreement
30th Sep 20247:00 amRNSInterim Results
11th Sep 20247:00 amRNSIssue of Equity
30th Apr 202412:30 pmRNSFinal Results
29th Jan 20247:00 amRNSIssue of Equity
29th Sep 20237:00 amRNSUnaudited Interim Results
16th Jun 20237:00 amRNSLifting of suspension, recommencement of trading
6th Jun 202310:11 amRNSREPLACEMENT: MOU WITH PARTNER IN GREATER CHINA
6th Jun 20239:13 amRNSMOU SIGNED WITH PARTNER IN GREATER CHINA
5th Jun 20233:02 pmRNSFinal results for the year ended 31 December 2022
2nd May 20237:57 amRNSDELAY IN PUBLISHING AUDITED FINANCIAL STATEMENTS
17th Apr 20237:00 amRNSHH Simonsen distributorship agreement update
30th Dec 20227:00 amRNSTotal Voting Rights
21st Dec 20227:00 amRNSIssue of Equity
27th Sep 20227:00 amRNSUnaudited Interim Results
30th Jun 20227:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.